A Randomised, Double-Blind, Two-Sequence, Single-Dose, Crossover Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, and Immunogenicity Profile of B-3E07 and Forsteo in Healthy Adult Female Participants
Latest Information Update: 06 Apr 2026
At a glance
- Drugs B 3E07 (Primary) ; Teriparatide
- Indications Diabetes mellitus
- Focus Pharmacokinetics
Most Recent Events
- 06 Apr 2026 New trial record